Establishment Labs and OBP Medical Announce Partnership to Deliver Innovative New Tool for Advanced Breast Aesthetics Procedures

Print
| Source: Establishment Labs

NEW YORK, Nov. 29, 2017 (GLOBE NEWSWIRE) -- Establishment Labs, a global medical device company focused on aesthetic technologies with a strong emphasis on product development and innovation, announced today the launch of the MotivaImagine Ultralight LED in partnership with OBP Medical, creators of the award winning ONETRAC Retractor family.

Surgical kits designed to support placement of Establishment Labs’ next-generation Motiva Implants® will now include the MotivaImagine Ultralight LED, a single-use, cordless surgical retractor and measurement device with integrated LED light source and smoke evacuation channel. The unique design and features make it an ideal tool for plastic surgeons performing Motiva MinimalScars breast augmentation. It delivers unmatched functionality, clinical efficiency and infection prevention for Motiva users in countries across the globe.   No assembly, additional parts/components, or fiber-optic cable are required.

"We are delighted to launch the MotivaImagine Ultralight LED with OBP Medical to increase the safety and efficacy profile of our Motiva Implants. With the launch of Motiva MinimalScars breast augmentation we will deliver added value to plastic surgeons and their patients," said Juan José Chacón Quirós, CEO and founder of Establishment Labs. "The MotivaImagine Ultralight LED is an evidence-based tool that eliminates the risk of cross contamination and integrates seamlessly into our implantation protocol for advanced breast aesthetics procedures."

“OBP Medical is committed to developing products that improve patient care and increase patient safety,” said Jason Swift, CEO of OBP Medical. “The clinical, operational and safety benefits of ONETRAC technology embodied in the MotivaImagine Ultralight LED make it the perfect choice for advanced procedures using Motiva Implants. Our partnership with Establishment Labs helps us meet demand for ONETRAC in new regions and we look forward to working together to put innovative surgical solutions into the hands of surgeons around the world.”

About Establishment Labs
Establishment Labs is a global, privately held, medical technology company with a strong emphasis on innovation that designs, develops, manufactures and markets an innovative product portfolio. Its CE-marked Motiva Implants® line of silicone breast implants (http://www.motivaimplants.com) utilizes ultra-high purity medical-grade silicone and is subject to the strictest quality assurance testing throughout the manufacturing process. Motiva Implants are sold in more than 60 countries worldwide. Puregraft®'s FDA cleared and CE-Marked technology provides plastic surgeons with purified fat for reinjection on the sterile field and is used in hospitals and clinics around the world. Divina® is a proprietary 3D imaging technology for full integration in consultation and surgical planning of unique solutions for breast aesthetics and reconstruction.  All manufacturing facilities are fully compliant with both FDA and ISO applicable standards.

About OBP Medical
OBP Medical is the leading global developer of single-use, self-contained, illuminating medical devices. We create simple and effective single-use solutions by integrating medical devices with LED light sources, making them one. At OBP Medical, we illuminate the everyday. Our innovative products are in use at more than 6,000 physician offices, surgery centers and hospitals throughout the U.S., as well as healthcare facilities worldwide. For more information about OBP Medical and our line of self-illuminated medical devices, please visit www.obpmedical.com, check out our Simple.Bright.Ideas.BLOG or follow us on Twitter. OBP Medical is proud to be ISO13485 certified.

Investor Relations Contact
Lynn Pieper Lewis or Leigh Salvo
Gilmartin Group
(415) 937-5404
leigh@gilmartinir.com